Transpharmation is a preclinical neuroscience CRO led by scientists. Operating globally, clients benefit from decades of reputational experience in translational biology across multiple neuroscience preclinical services. These include bioanalysis (small molecule and protein), EEG, cognitive assays across small and large animal species and models, epilepsy, pain, neurodegeneration and anxiety/mood disorders (including treatment-resistant depression and schizophrenia), in addition to a biomarker platform, human tissue capabilities, operant behaviour, imaging and automated assessment of spontaneous behaviour. Recently merged with North American CRO InterVivo Solutions, Transpharmation forms the largest boutique neuroscience-specialised CRO, with 120 staff, a delivery footprint extending across North America, UK and Europe, consulting capability across Japan and Asia, and elevated opportunities for collaboration. Science remains our passion. Delivering results for clients is our mission.